Global Health Limited — Important, 04-02-2025: Arrangements for strategic, technical, manufacturing, or marketing tie up

Global Health Limited's Board has approved the financial results for the quarter and nine months ended December 31, 2024, showing robust growth with total income at ₹28,172.35 Cr, increasing from ₹25,137.22 Cr YoY. The company reported a profit after tax of ₹3,799.40 Cr, surpassing ₹3,507.13 Cr from the previous year, driven by growth in healthcare services.

Additionally, plans for capacity expansion include a newly constructed 110-bed hospital in Ranchi, with an expected capital expenditure of up to ₹50 Cr to be financed through internal accruals. This strategic move is aimed at enhancing high-end tertiary healthcare services in the region.

The Board also approved the re-appointment of Ms. Praveen Mahajan as an Independent Director for a second term of five years, subject to shareholder approval. Overall, these developments indicate a positive outlook for Global Health, emphasizing their commitment to expanding their healthcare capabilities and services.